Xyrem gets CHMP positive opinion

The EMEA's CHMP issued a positive opinion to UCB (Euronext:UCB) for Xyrem sodium oxybate to treat cataplexy associated with narcolepsy. A decision is anticipated in the fourth quarter. UCB has EU righ...